This 8-hour, virtual-live course is the recommended first step to understanding the ASAM Criteria 3rd Edition and covers developing patient-centered service plans as well as making objective decisions about patient admission, continuing care, and transfer/discharge for individuals with addictive, substance-related, and co-occurring conditions.

This two-day course includes the ASAM Criteria 3rd Edition One-Day Foundations Course and the ASAM Criteria Third Edition Skill-Building Course at a discounted rate. Each course provides the tools to utilize the ASAM Criteria with the utmost care and evidence-based practice.

This 8-hour virtual live course is the recommended first step to understanding the ASAM Criteria 3rd Edition and covers developing patient-centered service plans as well as making objective decisions about patient admission, continuing care, and transfer/discharge for individuals with addictive, substance-related, and co-occurring conditions.

This two-day course includes the ASAM Criteria One-Day Foundations Course and the ASAM Criteria Skill-Building Course at a discounted rate. Each course provides the tools to utilize the ASAM Criteria with the utmost care and evidence-based practice.

This 8-hour virtual live course is the recommended first step to understanding the ASAM Criteria 3rd Edition and covers developing patient-centered service plans as well as making objective decisions about patient admission, continuing care, and transfer/discharge for individuals with addictive, substance-related, and co-occurring conditions.

This 1.5-hour live-virtual course is part of an online case-based learning collaborative series focused on treating opioid use disorder.

This one-hour, on-demand, journal article-based activity that reviews a recent study that examines death certificate data to assess the staggering increase in overdose death rates among Black and Indigenous women in Wisconsin from 2018 to 2020. According to the study, Wisconsin overdose deaths in this population increased 11-fold from 2000 to 2020, with over 1,200 deaths in 2020.

This one-hour, on-demand, journal article-based activity discusses original research on naloxone ​dosing for prevention of return to use in people with opioid use disorder. It examines the relationship between plasma levels of extended-release naltrexone (XR-NTX) and subjective responses to opioids in individuals with opioid use disorder (OUD), highlighting the importance of maintaining therapeutic naltrexone (NTX) levels.

This one-hour, on-demand, journal article-based activity compares characteristics of participants who reported using xylazine to those who reported not using xylazine in the past 12 months. Data from the National HIV Behavioral Surveillance Survey among persons who inject drugs (PWIDs) in Philadelphia was reviewed to better identify individuals at risk and inform patients and clinicians about xylazine risk factors.

This one-hour, on-demand, journal article-based activity examines the use of monthly subcutaneous injectable buprenorphine (XR-Bup) as an option for the treatment of opioid use disorder.